Global Human Microbiome Therapeutics Market Size, Status and Forecast 2019-2025

Choose Licence

 

Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics are therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyse the establishment of healthy ones. One of the major drivers for this market is side effects of the existing treatments. Various medicines available in the market have several side-effects including minor headaches. These medicines may also impart serious side-effects such as liver or kidney injury, heart problems, and even death. The seriousness of side-effects drives the need for innovative treatment technologies, such as human microbiome therapeutics, that have reduced the negative impact on the human body. The demand for microbiome therapeutics is increasing since it provides treatment sans chemicals. The latest trend gaining momentum in the market is growing investments from venture capitalists. Venture capitalists are capitalizing on the need for effective treatment and are offering therapeutic treatment solutions to treat disorders such as autoimmune disorders, infections, and cancer.? In 2018, the global Human Microbiome Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Human Microbiome Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Microbiome Therapeutics development in United States, Europe and China. The key players covered in this study Enterome Bioscience Rebiotix Seres Therapeutics Vedanta Biosciences Bristol-Myers Squibb Johnson & Johnson Takeda Pharmaceutical ... Market segment by Type, the product can be split into FMT Microbiome Drugs Market segment by Application, split into C. difficile Crohn?s Disease Inflammatory Bowel Disease Diabetes Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Human Microbiome Therapeutics status, future forecast, growth opportunity, key market and key players. To present the Human Microbiome Therapeutics development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Human Microbiome Therapeutics are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 FMT 1.4.3 Microbiome Drugs 1.5 Market by Application 1.5.1 Global Human Microbiome Therapeutics Market Share by Application (2014-2025) 1.5.2 C. difficile 1.5.3 Crohn?s Disease 1.5.4 Inflammatory Bowel Disease 1.5.5 Diabetes 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Human Microbiome Therapeutics Market Size 2.2 Human Microbiome Therapeutics Growth Trends by Regions 2.2.1 Human Microbiome Therapeutics Market Size by Regions (2014-2025) 2.2.2 Human Microbiome Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Human Microbiome Therapeutics Market Size by Manufacturers 3.1.1 Global Human Microbiome Therapeutics Revenue by Manufacturers (2014-2018) 3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Manufacturers (2014-2018) 3.1.3 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Human Microbiome Therapeutics Key Players Head office and Area Served 3.3 Key Players Human Microbiome Therapeutics Product/Solution/Service 3.4 Date of Enter into Human Microbiome Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Human Microbiome Therapeutics Market Size by Type (2014-2019) 4.2 Global Human Microbiome Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Human Microbiome Therapeutics Market Size (2014-2019) 5.2 Human Microbiome Therapeutics Key Players in United States 5.3 United States Human Microbiome Therapeutics Market Size by Type 5.4 United States Human Microbiome Therapeutics Market Size by Application 6 Europe 6.1 Europe Human Microbiome Therapeutics Market Size (2014-2019) 6.2 Human Microbiome Therapeutics Key Players in Europe 6.3 Europe Human Microbiome Therapeutics Market Size by Type 6.4 Europe Human Microbiome Therapeutics Market Size by Application 7 China 7.1 China Human Microbiome Therapeutics Market Size (2014-2019) 7.2 Human Microbiome Therapeutics Key Players in China 7.3 China Human Microbiome Therapeutics Market Size by Type 7.4 China Human Microbiome Therapeutics Market Size by Application 8 Japan 8.1 Japan Human Microbiome Therapeutics Market Size (2014-2019) 8.2 Human Microbiome Therapeutics Key Players in Japan 8.3 Japan Human Microbiome Therapeutics Market Size by Type 8.4 Japan Human Microbiome Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Human Microbiome Therapeutics Market Size (2014-2019) 9.2 Human Microbiome Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Human Microbiome Therapeutics Market Size by Type 9.4 Southeast Asia Human Microbiome Therapeutics Market Size by Application 10 India 10.1 India Human Microbiome Therapeutics Market Size (2014-2019) 10.2 Human Microbiome Therapeutics Key Players in India 10.3 India Human Microbiome Therapeutics Market Size by Type 10.4 India Human Microbiome Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Human Microbiome Therapeutics Market Size (2014-2019) 11.2 Human Microbiome Therapeutics Key Players in Central & South America 11.3 Central & South America Human Microbiome Therapeutics Market Size by Type 11.4 Central & South America Human Microbiome Therapeutics Market Size by Application 12 International Players Profiles 12.1 Enterome Bioscience 12.1.1 Enterome Bioscience Company Details 12.1.2 Company Description and Business Overview 12.1.3 Human Microbiome Therapeutics Introduction 12.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2014-2019) 12.1.5 Enterome Bioscience Recent Development 12.2 Rebiotix 12.2.1 Rebiotix Company Details 12.2.2 Company Description and Business Overview 12.2.3 Human Microbiome Therapeutics Introduction 12.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2014-2019) 12.2.5 Rebiotix Recent Development 12.3 Seres Therapeutics 12.3.1 Seres Therapeutics Company Details 12.3.2 Company Description and Business Overview 12.3.3 Human Microbiome Therapeutics Introduction 12.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2014-2019) 12.3.5 Seres Therapeutics Recent Development 12.4 Vedanta Biosciences 12.4.1 Vedanta Biosciences Company Details 12.4.2 Company Description and Business Overview 12.4.3 Human Microbiome Therapeutics Introduction 12.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2014-2019) 12.4.5 Vedanta Biosciences Recent Development 12.5 Bristol-Myers Squibb 12.5.1 Bristol-Myers Squibb Company Details 12.5.2 Company Description and Business Overview 12.5.3 Human Microbiome Therapeutics Introduction 12.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2014-2019) 12.5.5 Bristol-Myers Squibb Recent Development 12.6 Johnson & Johnson 12.6.1 Johnson & Johnson Company Details 12.6.2 Company Description and Business Overview 12.6.3 Human Microbiome Therapeutics Introduction 12.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2014-2019) 12.6.5 Johnson & Johnson Recent Development 12.7 Takeda Pharmaceutical 12.7.1 Takeda Pharmaceutical Company Details 12.7.2 Company Description and Business Overview 12.7.3 Human Microbiome Therapeutics Introduction 12.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2014-2019) 12.7.5 Takeda Pharmaceutical Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Human Microbiome Therapeutics Key Market Segments Table Key Players Human Microbiome Therapeutics Covered Table Global Human Microbiome Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Human Microbiome Therapeutics Market Size Market Share by Type 2014-2025 Figure FMT Figures Table Key Players of FMT Figure Microbiome Drugs Figures Table Key Players of Microbiome Drugs Table Global Human Microbiome Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure C. difficile Case Studies Figure Crohn?s Disease Case Studies Figure Inflammatory Bowel Disease Case Studies Figure Diabetes Case Studies Figure Others Case Studies Figure Human Microbiome Therapeutics Report Years Considered Table Global Human Microbiome Therapeutics Market Size 2014-2025 (Million US$) Figure Global Human Microbiome Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Human Microbiome Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Human Microbiome Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Human Microbiome Therapeutics Market Share by Regions 2014-2019 Figure Global Human Microbiome Therapeutics Market Share by Regions 2014-2019 Figure Global Human Microbiome Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Human Microbiome Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Human Microbiome Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Human Microbiome Therapeutics Market Share by Manufacturers in 2018 Table Global Human Microbiome Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Human Microbiome Therapeutics Product/Solution/Service Table Date of Enter into Human Microbiome Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Human Microbiome Therapeutics Market Size Share by Type (2014-2019) Figure Global Human Microbiome Therapeutics Market Size Market Share by Type (2014-2019) Table Global Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Human Microbiome Therapeutics Market Size Share by Application (2014-2019) Figure Global Human Microbiome Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Human Microbiome Therapeutics Revenue Market Share by Application in 2018 Figure United States Human Microbiome Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Human Microbiome Therapeutics Market Share (2018-2019) Table United States Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Human Microbiome Therapeutics Market Share by Type (2014-2019) Table United States Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Human Microbiome Therapeutics Market Share by Application (2014-2019) Figure Europe Human Microbiome Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Human Microbiome Therapeutics Market Share (2018-2019) Table Europe Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Human Microbiome Therapeutics Market Share by Type (2014-2019) Table Europe Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Human Microbiome Therapeutics Market Share by Application (2014-2019) Figure China Human Microbiome Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Human Microbiome Therapeutics Market Share (2018-2019) Table China Human Microbiome Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Human Microbiome Therapeutics Market Share by Type (2014-2019) Table China Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Human Microbiome Therapeutics Market Share by Application (2014-2019) Figure Japan Human Microbiome Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Human Microbiome Therapeutics Market Share (2018-2019) Table Japan Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Human Microbiome Therapeutics Market Share by Type (2014-2019) Table Japan Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Human Microbiome Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Human Microbiome Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Human Microbiome Therapeutics Market Share (2018-2019) Table Southeast Asia Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Human Microbiome Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Human Microbiome Therapeutics Market Share by Application (2014-2019) Figure India Human Microbiome Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Human Microbiome Therapeutics Market Share (2018-2019) Table India Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Human Microbiome Therapeutics Market Share by Type (2014-2019) Table India Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Human Microbiome Therapeutics Market Share by Application (2014-2019) Figure Central & South America Human Microbiome Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Human Microbiome Therapeutics Market Share (2018-2019) Table Central & South America Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Human Microbiome Therapeutics Market Share by Type (2014-2019) Table Central & South America Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Human Microbiome Therapeutics Market Share by Application (2014-2019) Table Enterome Bioscience Company Details Table Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2014-2019) (Million US$) Figure Enterome Bioscience Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019) Table Enterome Bioscience Recent Development Table Rebiotix Company Details Table Rebiotix Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$) Figure Rebiotix Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019) Table Rebiotix Recent Development Table Seres Therapeutics Company Details Table Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$) Figure Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019) Table Seres Therapeutics Recent Development Table Vedanta Biosciences Company Details Table Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$) Figure Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019) Table Vedanta Biosciences Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$) Figure Johnson & Johnson Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019) Table Johnson & Johnson Recent Development Table Takeda Pharmaceutical Company Details Table Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$) Figure Takeda Pharmaceutical Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019) Table Takeda Pharmaceutical Recent Development Table Global Human Microbiome Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Human Microbiome Therapeutics Market Size Share by Regions (2019-2025) Figure Global Human Microbiome Therapeutics Market Size Share by Regions in 2025 Figure United States Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Human Microbiome Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Human Microbiome Therapeutics Market Size by Product (2019-2025) Figure Global Human Microbiome Therapeutics Market Size by Product in 2025 Table Global Human Microbiome Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Human Microbiome Therapeutics Market Size by Application (2019-2025) Figure Global Human Microbiome Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Aircraft Wire & Cable Market Research Report 2019

Aerospace Wire?& Cable is a leader of high temperature custom wire & cable. The global Aircraft Wire & Cable market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-20...

Global Electrosurgical Cutting Forcep Market Research Report 2019

Electrosurgical cutting forcep are designed for precision use with our electrosurgery unit. Electrosurgery allows for cutting, blended cutting, coagulating, fulgurating and bipolar applications. The global Electrosurgical Cutting Forcep market is ...

Global Electrosurgical Unit Handle Market Research Report 2019

Electrosurgical Unit Handle?are used to connect electrodes and auxiliary instruments to RF?units?for monopolar cutting or coagulation. The global Electrosurgical Unit Handle market is valued at xx million US$ in 2018 is expected to reach xx millio...

Global Monopolar Cutting Electrosurgical Unit Market Research Report 2019

Electrosurgery?makes use of high-frequency electrical current to cut, coagulate, desiccate, and fulgurate tissue and can be performed using either monopolar or bipolar-energy in conjunction with a specialized instrument. Each of these two modalities ...

Global Cutting Electrosurgical Unit Market Research Report 2019

Electrosurgery?makes use of high-frequency electrical current to cut, coagulate, desiccate, and fulgurate tissue and can be performed using either monopolar or bipolar-energy in conjunction with a specialized instrument. Each of these two modalities ...

New Pharmaceuticals and Healthcare Reports